DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Brown Michael Jon
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 10-Q: Quarterly report
DexCom | 8-K: Dexcom Reports Second Quarter 2024 Financial Results, Updates Guidance, and Announces $750 Million Share Repurchase Program
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Brown Michael Jon
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 4: Statement of changes in beneficial ownership of securities-Director FOLETTA MARK G
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Heller Bridgette P
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Sylvain Jereme M
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Stern Sadie
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Leach Jacob Steven
DexCom | 4: Statement of changes in beneficial ownership of securities-Officer Brown Michael Jon
DexCom | 144: Notice of proposed sale of securities pursuant to Rule 144
DexCom | SD: Specialized disclosure report
DexCom | 4: Statement of changes in beneficial ownership of securities-Director TOPOL ERIC
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Malady Kyle
DexCom | 4: Statement of changes in beneficial ownership of securities-Director Heller Bridgette P
No Data